Evacetrapib and Cardiovascular Outcomes: Reasons for Lack of Efficacy

Journal of Thoracic Disease - Hong Kong
doi 10.21037/jtd.2017.07.75
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2017English

Epistemological Reasons for Lack of Science in Ancient China

Open Journal of Social Sciences
2015English

Ways of Identifying the Reasons for the Lack of Full Protective Layer Application Effects

Transportation Overview - Przeglad Komunikacyjny
2018English

Inpatient Hemodialysis Initiation: Reasons, Risk Factors and Outcomes

Nephron Clinical Practice
2010English

Lack of Efficacy of Eplerenone for Treatment of Active Central Serous Chorioretinopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2020English

Opportunities for Improving Global Cardiovascular Quality of Care and Outcomes

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2014English

Sudden Deaths in Sports Due to Cardiovascular Reasons

INTERNATIONAL REFEREED JOURNAL OF ORTHOPAEDICS TRAUMATOLOGY AND SPORTS MEDICINE
2014English

Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Diabetic Outcomes: Cardiovascular Outcomes With Lipid modificationH 2D

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy